Transaction in Own Shares

Summary by AI BETAClose X

On September 19, 2025, Coca-Cola Europacific Partners plc purchased 33,735 ordinary shares on US Trading Venues at prices ranging from USD 89.2500 to USD 90.0000, with a volume-weighted average price of USD 89.6250. Additionally, the company bought back 28,006 ordinary shares on the London Trading Venues, including 19,099 on the London Stock Exchange, 4,376 on CBOE Europe Limited (CXE), 4,121 on CBOE Europe Limited (BXE), and 410 on Aquis. The prices paid per share on the London Trading Venues ranged from GBP 66.0000 to GBP 66.6000, with volume-weighted average prices of GBP 66.3648, GBP 66.3557, GBP 66.3878, and GBP 66.4000, respectively. These repurchased shares will be cancelled as part of a share buyback program expecting to repurchase up to EUR 1 billion of ordinary shares.

Disclaimer*

Coca-Cola Europacific Partners plc
22 September 2025
 

Coca-Cola Europacific Partners plc (the "Company")
Transactions in Own Shares

 

The Company confirms that on 19 September 2025 it purchased a total of: (i) 33,735 ordinary shares of EUR 0.01 ("ordinary shares") on the US Trading Venues[1] and (ii) 28,006 ordinary shares on the London Trading Venues[2]; in both cases, from Goldman Sachs & Co. LLC, Goldman Sachs International or one of their affiliates, as detailed below.

The repurchased ordinary shares will be cancelled.

 

US Trading Venues

London Stock Exchange

CBOE Europe Limited

(CXE)

 

CBOE Europe Limited

(BXE)

Aquis

Date of purchase

19 September 2025

19 September 2025

19 September 2025

19 September 2025

19 September 2025

Aggregate number of ordinary shares purchased

33,735

19,099

4,376

4,121

 

 

410

Highest price paid (per ordinary share)

USD 90.0000

GBP 66.6000

GBP 66.6000

GBP 66.6000

GBP 66.4000

Lowest price paid (per ordinary share)

USD 89.2500

GBP 66.0000

GBP 66.0000

GBP 66.1000

 

GBP 66.4000

 

Volume weighted average price paid (per ordinary share)

USD 89.6250

GBP 66.3648

GBP 66.3557

GBP 66.3878

 

GBP 66.4000

 

 

The purchases form part of the Company's share buyback programme announced on 14 February 2025 (the "Programme"). In connection with the Programme, the Company expects to repurchase up to EUR 1 billion of ordinary shares (in aggregate).

This announcement does not constitute, or form part of, an offer or solicitation of an offer for securities in any jurisdiction.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), full details of the transactions, are set out in the Schedule to this announcement available through the link below:

http://www.rns-pdf.londonstockexchange.com/rns/2170A_1-2025-9-21.pdf

 



CONTACTS

Company Secretariat

Clare Wardle

clare.wardle@ccep.com

 

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock Exchange and on the Spanish Stock Exchanges, and a constituent of both the NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP.

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

 

 

 

 

 

 



[1] The "US Trading Venues" comprise Nasdaq and other applicable US trading venues.

[2] The "London Trading Venues" comprise the London Stock Exchange, CBOE Europe Limited (BXE) and CBOE Europe Limited (CXE) and Aquis. Goldman Sachs acquired CREST Depositary Interests on the London Trading Venues, which will be cancelled together with the underlying shares they represent.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings